
|Videos|April 29, 2022
ViaLase technology could impact glaucoma care for patients worldwide
Author(s)Kassi Filkins
Kevin Waltz, a consultant for ViaLase, discusses the company's technology: an image-guided femtosecond laser surgical system for the treatment of glaucoma.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Ocular Therapeutix reaches target enrollment of 555 patients in SOL-R trial
2
4DMT and Otsuka Pharmaceutical partner on 4D-150 in the greater Asia-Pacific region
3
AAVantgarde Bio closes $141 million Series B financing round
4
Nanoscope Therapeutics releases positive long-term safety results from EXTEND study
5


















































.png)


